Articles on Pharmaceuticals
Displaying 141 - 160 of 262 articles
The Trump administration’s proposal to lower drug prices focuses on discounts. A health policy scholar argues that the US could learn from Europe’s system of measuring drug value and effectiveness.
Clinical guidelines have a big impact on the care you receive and the drugs you’re prescribed. But one in five doctors who write these guidelines have undisclosed ties to drug companies.
Don’t mix your statins with grapefruit, or leafy green vegetables with warfarin.
Pharmaceuticals were found in every invertebrate sampled from six Melbourne streams - including a waterway in a national park.
A new book, ‘The Thalidomide Catastrophe,’ raises new questions about the conduct of corporations involved. It is the duty of governments to find out the answers.
Drug trials should include people with more than one disease.
Small-batch brewers are starting to tinker with biologic drugs to meet their own medical needs. A side effect of their success would be a disruption to how big pharma makes and distributes drugs.
Could issues like price manipulation and over-regulation be having an impact on the medicine supply chain?
In the run up to the Global Hepatitis Summit 2018, new guidelines for the management of hepatitis C should come under scrutiny – for financial conflict of interest and quality of evidence.
Medical cannabis challenges scientific norms and the usual regulation of medicines.
Researchers who’ve created a kidney-on-a-chip explain why these kinds of devices are an improvement over traditional ways to test new drugs.
Prescription drugs are policed by industry and Health Canada has never prosecuted a drug company for illegally marketing a drug.
Pharmaceutical companies focus on small molecules they’ve devised – and can easily patent. But nature’s already come up with many antibacterial compounds that drug designers could use to make medicines.
Congress has sent a bill to the White House. It gives terminally-ill patients more false hope than chances for a cure.
Researchers use an algorithm designed to help robots move to figure out what’s possible when designing new molecules in a promising class of pharmaceuticals.
How a technology born from finance – the blockchain – can help the pharmaceutical industry to carry out clinical trials that protect patients.
If you look into your kitchen or bathroom cabinet, chances are you’d find some unused medicine, much of it expired. Here’s what to do with it.
The choke factor is visible in tournament-style athletics competitions, and should teach managers about incentives.
As the government moves ahead with its industrial plan, a new report signals it will have to start doing things differently.
A trial of methylprednisolone in kidney patients was halted recently because of safety concerns. But this doesn’t affect people taking the drug for asthma, arthritis or other inflammatory conditions.



















